Recently, the FDA has sent a warning letter to the Allergan company, concerning its new drug Latisse.  It addressing the fact  that some of the information about Latisse may be misleading.  The FDA is concerned that the promotional materials describing the new drug to grow eyelashes, does not adequately inform the consumer about the risks and side effects.  Allergan, (according to the FDA) should tell the consumer more about the reasons why not apply Latisse only to the upper eyelid…unwanted growth to lower eyelids, also to warn about possible  eyelid darkening side effects more prominently.

The FDA warns that redness and itching can cause damage to the eyes, facts the consumer should be aware of in the promotional materials.

What this all means is that Latisse will probably have to have more extensive warnings on their new drug to grow lashes longer.  Some promotional material will have to include information the FDA deems more factual and appropriate.  When using this drug or any drug, be aware of possible side effects, and talk to your doctor about your particular situation before using any medication.